Wisconsin National Primate Research Center

What Wisconsin National Primate Research Center does

The Wisconsin National Primate Research Center (WNPRC) is a federally designated National Primate Research Center operating within the University of Wisconsin-Madison, one of only seven such centers in the United States. Founded in 1960, WNPRC provides nonhuman primate research models—primarily rhesus macaques and common marmosets—for preclinical research into human health conditions including neurodegenerative diseases (Parkinson's, Alzheimer's), infectious diseases (HIV, Zika, influenza, tuberculosis), reproductive health, and regenerative medicine. Its core technology platforms include CRISPR-based gene editing, individualized stem cell grafts, PET imaging for neurodegenerative disease tracking, and kidney transplant tolerance models using mixed chimerism approaches.

WNPRC operates a service-oriented business model structured around three revenue streams. First, it delivers research services (Assay, Immunology, Virology, Genomics) and animal services (Veterinary, Colony, Behavioral, Pathology, Scientific Protocol Implementation, Compliance & Safety) through 215 service contracts with external research institutions nationwide. Second, it receives federal funding through the NIH Office of Research Infrastructure Programs as one of seven designated NPRCs. Third, it accepts philanthropic donations via the University of Wisconsin Foundation. The center maintains strategic partnerships with Stanford, Harvard, Boston College, the University of Pittsburgh, the University of California-Davis, and international collaborators in the Netherlands.

The center serves academic and medical researchers as its primary customer segment, with secondary engagement from pharmaceutical/biotechnology companies requiring preclinical testing and students/trainees receiving research education. Notable outputs include the first derivation of human embryonic stem cells (James Thomson), Parkinson's cell therapy now in human clinical trials, and gene-edited monkey models for HIV cure research. WNPRC does not have external private equity or venture capital ownership, and its budget is not reported separately from the University of Wisconsin System.

Name

Wisconsin National Primate Research Center

Legal name

Wisconsin National Primate Research Center

Website

https://primate.wisc.edu

Company type

Private

Founded year

1960

Operating status

Operating

Headcount range

101–250 employees

Short description

WNPRC is one of seven NIH-designated National Primate Research Centers, providing nonhuman primate research models and preclinical services to academic, government, and biopharma researchers through 215 service contracts and federal grant funding.

Ownership category

akta.pro rank

Product category

Biomedical Research Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Veterinary Services (54194)

SIC

Services-Commercial Physical & Biological Research (8731), Services-Health Services (8000)

akta.pro primary industry

One Health & Zoonotic Disease Partnerships (Human–Animal–Environment) (HLAJAOAJ)

akta.pro secondary industries

Global Health Research, Clinical Trials & Product Development Partnerships (PDPs) (HLAJAOAM), Vaccine R&D, Clinical/Field Trials & Regulatory Affairs (HLAMAKAM), Clinical Research, Trials & Translational Services (Veterinary Regenerative) (HLAMANAL), Zoonotic & One Health Public Health Laboratory Networks (HLAJAIAI)

Keywords

• Nonhuman primate research
• Preclinical research services
• Biomedical research services
• Translational medicine research
• Animal care services

Headquarters

HQ city

Madison

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Research Services Contracts: The center generates revenue through providing research services to external researchers and institutions. Services include Assay, Immunology, Virology, Genomics, Veterinary, Colony, Behavioral, Pathology, Scientific Protocol Implementation, and Compliance & Safety services. The center has 215 service contracts nationwide.
2. Grant Funding: As a National Primate Research Center, the center receives NIH funding through the Office of Research Infrastructure Programs to support primate research programs
3. Donations and Philanthropy: The center accepts charitable donations through the University of Wisconsin Foundation to support life-saving research conducted at the center

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

The Wisconsin National Primate Research Center (WNPRC) conducts nonhuman primate research using rhesus macaques and common marmosets to study human health conditions and provides comprehensive research services to external researchers and institutions. Core offerings include Research Services (Assay, Immunology, Virology, and Genomics), Animal Services (Veterinary, Colony, Behavioral, Pathology, Scientific Protocol Implementation, and Compliance & Safety), and Research Resources such as the Precision Genomics and Stem Cell Therapies Unit and Pilot Grant Awards Program. The center operates through 215 service contracts nationwide and supports translational research from basic discovery to clinical application.

Product overview

The Wisconsin National Primate Research Center is a research institution that provides a comprehensive suite of research services, animal care services, and research resources. The center offers Research Services (Assay, Immunology, Virology, and Genomics), Animal Services (Veterinary, Colony, Behavioral, Pathology, Scientific Protocol Implementation, Compliance & Safety), and Research Resources including the Precision Genomics and Stem Cell Therapies Unit and Pilot Grant Awards Program. These services support the center's mission to improve human and animal health through nonhuman primate research.

Differentiator

Problem solved

Functional benefit

Products and services

• Research Services Comprehensive research services including Assay, Immunology, Virology, and Genomics provided to external researchers and institutions through service contracts. Used by academic and medical researchers requiring nonhuman primate-based preclinical research support.
• Animal Services Comprehensive animal care services including Veterinary, Colony, Behavioral, Pathology, Scientific Protocol Implementation, and Compliance & Safety services. Provided to research institutions requiring nonhuman primate animal care and welfare support.
• Precision Genomics and Stem Cell Therapies Unit Specialized research resource providing precision genomics and stem cell therapies research support, including regenerative medicine research capabilities for investigators.

Quantifiable outcome

• First human embryonic stem cells derived at WNPRC, launching regenerative medicine era
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Ten partnerships are on record, tiered core, major and minor.

• National Primate Research Centers NetworkcoreStrategic or Co-development PartnerCollaboration with six other National Primate Research Centers across the United States for shared research resources, collaborative studies, and best practices. The center actively participates in joint initiatives including Zika virus research, HIV/AIDS studies, and tuberculosis vaccine development.
• University of Wisconsin-Madison School of Medicine and Public HealthcoreStrategic or Co-development PartnerIntegrated partnership with UW-Madison for preclinical and clinical research programs. WNPRC provides research infrastructure while UW researchers conduct studies in Parkinson's disease, stem cell research, and other areas.
• Stanford School of MedicinemajorStrategic or Co-development PartnerCollaboration with Samuel Strober, MD at Stanford for transplant tolerance research using mixed chimerism approaches. Stanford's protocol for matched transplants combined with UW-Madison's primate model capabilities.
• Boston College and Harvard UniversitymajorStrategic or Co-development PartnerCollaboration with James Whitney at Boston College and Harvard University for HIV treatment research published in Science, advancing to clinical trials.
• University of PittsburghmajorStrategic or Co-development PartnerPartnership for tuberculosis research in SIV-infected macaques, developing new vaccine strategies for TB protection.
• University of FloridaminorStrategic or Co-development PartnerCollaboration with Helen Jones from University of Florida on gene therapy research for placental disorders and pregnancy outcomes.
• Loyola MedicineminorStrategic or Co-development PartnerCollaboration with transplant surgeon Luis Fernandez for kidney transplant research, now at Loyola Medicine in Chicago.
• Pharming Technologies BVminorStrategic or Co-development PartnerInternational collaboration with pharmaceutical company in Leiden, Netherlands for kidney transplant complement blockade therapy research.
• Leiden University Medical CenterminorStrategic or Co-development PartnerPartnership with academic medical center in Netherlands for transplant research collaboration.
• University of California-DavisminorStrategic or Co-development PartnerCollaboration with Peter Barry and Cecilia Penedo at UC-Davis for post-transplant sample testing including viral infection and chimerism monitoring.

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Tulane National Primate Research Center: One of the seven NPRCs, focused intensively on infectious disease (HIV, Lyme, TB, Zika) — directly overlapping with several of WNPRC's signature programs including TB-in-SIV-macaques vaccine work.
• Yerkes National Primate Research Center (Emory University): One of the seven NPRCs, hosted at Emory. Conducts comparable biomedical, neuroscience, and infectious-disease research in NHP models and shares the NPRC network collaboration model.
• Oregon National Primate Research Center (OHSU): One of the seven NIH-funded NPRCs located at OHSU. Operates the same NIH base-grant model with rhesus macaque and Japanese macaque colonies covering reproductive biology, neuroscience, and infectious disease — the most directly comparable NPRC peer.
• Southwest National Primate Research Center (Texas Biomedical Research Institute): One of the seven NPRCs, located at Texas Biomedical Research Institute. Operates baboon and rhesus macaque colonies with strong infectious-disease and metabolic-disease programs comparable to WNPRC.
• Washington National Primate Research Center (UW): One of the seven NPRCs at the University of Washington. Another NIH-funded NPRC peer with significant NHP infectious-disease and translational research overlap with WNPRC.
• California National Primate Research Center (UC Davis): Another of the seven NPRCs. CNPRC operates the largest rhesus macaque breeding colony in the US and runs infectious-disease and translational programs that overlap directly with WNPRC. Peter Barry and Cecilia Penedo (named in WNPRC collaborations) are faculty there.

Broad incumbents

• Charles River Laboratories: Largest commercial preclinical CRO offering NHP research services among a much broader portfolio. Comparable on the NHP-preclinical-service-contract dimension, but operates commercially across multiple animal models and therapeutic areas rather than specializing in primate work.
• The Jackson Laboratory: NIH-supported nonprofit research institute focused on mouse genetics with expanding NHP capabilities. Comparable as an NIH-funded biomedical research resource, though its primary platform (mice) differs from WNPRC's primate focus.
• Labcorp Drug Development (formerly Covance): Global CRO offering NHP toxicology and preclinical services within a full clinical-trial-services portfolio. Comparable on the contract NHP-research services dimension but as part of a much larger diagnostics and drug-development conglomerate.

Emerging players

• Altasciences: Mid-sized preclinical CRO offering safety-pharmacology and NHP toxicology services. Comparable as a contract NHP-research service provider but at smaller scale and with a primarily commercial (rather than federally-funded) revenue model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/wisconsin-national-primate-research-center

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Wisconsin National Primate Research Center